News

Erwinaze Gains IV Administration Approval

Jazz announced that the Food and Drug Administration has approved the intravenous (IV) administration of Erwinaze (asparaginase Erwinia chrysantheum).

New Inj Combo Antibiotic Approved for Complicated UTI, IAI

Cubist announced that the Food and Drug Administration (FDA) has approved Zerbaxa (ceftolozane/tazobactam) Injection for the treatment of adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) caused by susceptible Gram-negative bacteria.

Annual Eye Exam for Preschool Children Advised

All children should have an eye exam between the ages of 3-6, preferably every year, according to new vision-screening recommendations for preschool-aged children.

Tips Offered to Docs, Spouses for Maintaining Happy Marriage

Simple tips can help physicians and their spouses maintain marital happiness, according to a new article.

Novel HCV Infection Combo Tx Gets FDA OK

The Food and Drug Administration (FDA) has approved Viekira Pak (ombitasvir, paritaprevir, ritonavir with dasabuvir tablets; AbbVie) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection, including cirrhosis.

Wearables Predicted to Save 1.3 Million Lives By 2020

Smart wearable devices could help to save as many as 1.3 million lives by the year 2020, according to a report from Soreon Research.

Tempol, Antibiotics Promising as Nonalcoholic Fatty Liver Disease Tx

Inhibiting an intestinal nuclear receptor using tempol and antibiotics appears to be a promising treatment for nonalcoholic fatty liver disease (NAFLD).

Many Patients Don't Trust Doctors, Yet Satisfied with Care

A survey in the New England Journal of Medicine has found that the United States ranks third out of 29 countries in patient satisfaction from treatment received at their last visit with a doctor, but 24th in patient trust of doctors overall.

Can IV Acetaminophen Reduce Opioid Use for Postoperative Pain?

Multimodal analgesia for postoperative pain may help to reduce opioid use and decrease opoid-associated adverse effects, but is there an opioid-sparing effect with use of intravenous (IV) acetaminophen?

First-in-Class Drug for Advanced Ovarian Cancer Approved

The Food and Drug Administration (FDA) has granted accelerated approval for Lynparza (olaparib; AstraZeneca) for the treatment of advanced ovarian cancer associated with defective BRCA genes.